Indeed, protein levels of NSD2 and SRC-3 were both elevated concomitantly with H3K36me2 in BTZ-resistant myeloma cells, independent of cytogenetic backgrounds, but this elevation was not observed in p300 or PRMT4 (Fig. 4c, Fig. S3a). The gene discussed is NSD2; the disease is plasma cell myeloma.